Gene-expression regulated by epigenetic modifications, such as alter DNA accessibility and chromatin structure, histone modification, and DNA methylation 1,2
Le cofacteur endogne L-carnitine est capable de favoriser la -oxydation mitochondriale vers un mtabolisme nergtique cardiaque quilibr
Nature Communications, 12(1), 470
Many patients experience significant reductions in body weight, often averaging 15-20% of total body weight, making Tirzepatide a powerful tool in comprehensive, medically supervised weight management
At the two-year mark, 77.1% of semaglutide participants maintained at least 5% weight loss versus 34.4% on placebo
You may benefit from a medically supervised weight loss program if: You have a BMI of 27 or higher with a weight-related condition (diabetes, hypertension, sleep apnea) You have a BMI of 30 or higher regardless of other conditions You have tried diet and exercise but have been unable to maintain weight loss You have been diagnosed with insulin resistance, pre-diabetes, or metabolic syndrome You have a thyroid disorder or hormonal imbalance contributing to weight gain You are interested in GLP-1 medications like semaglutide or tirzepatide Frequently Asked Questions Do you prescribe semaglutide (Ozempic/Wegovy) or tirzepatide (Mounjaro/Zepbound)